Evidence map›Paper›PMID 40471322›Full record

ArticleInternational ophthalmology2025

Rising consultations for suspected papilledema: clinical and neuro-ophthalmologic insights.

Serife Ciloglu Hayat, Yusuf Cem Yilmaz, Kerem Davulcu, Sadik Altan Ozal

Abstract read
PubMed Publisher
In one paragraph

Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Serife Ciloglu HayatUniversity of Health Sciences, Basaksehir Cam and Sakura City Hospital, Department of Ophthalmology, Istanbul, Turkey., Basaksehir Cam and Sakura City Hospital, Basaksehir Olympic Boulevard Road, 34480, Basaksehir/Istanbul, Turkey. serifeciloglu@gmail.com.
Yusuf Cem YilmazUniversity of Health Sciences, Basaksehir Cam and Sakura City Hospital, Department of Ophthalmology, Istanbul, Turkey., Basaksehir Cam and Sakura City Hospital, Basaksehir Olympic Boulevard Road, 34480, Basaksehir/Istanbul, Turkey.
Kerem DavulcuUniversity of Health Sciences, Basaksehir Cam and Sakura City Hospital, Department of Ophthalmology, Istanbul, Turkey., Basaksehir Cam and Sakura City Hospital, Basaksehir Olympic Boulevard Road, 34480, Basaksehir/Istanbul, Turkey.
Sadik Altan OzalUniversity of Health Sciences, Basaksehir Cam and Sakura City Hospital, Department of Ophthalmology, Istanbul, Turkey., Basaksehir Cam and Sakura City Hospital, Basaksehir Olympic Boulevard Road, 34480, Basaksehir/Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo determine the prevalence of papilledema among patients referred for suspected papilledema and identify symptoms associated with increased intracranial pressure.

methodsThis retrospective study included 514 patients referred to the ophthalmology clinic with suspected papilledema. Patient records were reviewed for demographic details, symptoms, and diagnostic outcomes. Examinations included best-corrected visual acuity (BCVA) assessments, fundoscopic evaluations, visual field (VF) tests, optical coherence tomography (OCT)-retinal nerve fiber layer (RNFL) thickness and fundus photographs. The rates of detected papilledema and pseudopapilledema, along with associated symptoms, were evaluated.

resultsOf 514 patients, papilledema was diagnosed in 109 cases (21.2%). Idiopathic intracranial hypertension was the most common etiology (n = 91), yet cases with serious underlying causes, such as intracranial tumors (n = 5) and cerebral venous sinus thrombosis (n = 5), were also identified. Headache was a frequent symptom but showed no significant correlation with papilledema (p = 0.653), while transient visual obscurations (TVOs) demonstrated a strong association (p < 0.001). Among papilledema patients, 33 had full BCVA, and 37 had a VF MD of - 2 dB or better. Abnormal VF (MD worse than - 2 dB) was found in 36.4% of patients with full BCVA. It was observed that the RNFL thickness in all quadrants was greater in the papilledema group compared to the healthy optic disc group. Pseudopapilledema, present in 20 patients (3.9%), was frequently due to optic disc drusen. There were no statistically significant differences in symptoms between patients with papilledema and those with pseudopapilledema.

conclusionPapilledema screening is a common consultation, particularly in the presence of accompanying symptoms, and accurate evaluation is crucial, especially for patients presenting with TVOs. Abnormal VFs were detected in patients with normal BCVA, most commonly presenting as an enlarged blind spot. This highlights that BCVA alone is insufficient for diagnosing and monitoring suspected papilledema. Recognizing papilledema is vital given its association with conditions carrying significant morbidity and mortality risks, such as intracranial tumors and thrombosis. Enhanced ophthalmoscopy skills among referring physicians may streamline the referral process, reduce unnecessary consultations, and improve patient outcomes by enabling timely intervention for high-risk cases.

Indexed as

PapilledemaReferral and ConsultationVisual AcuityVisual FieldsAdolescentAdultAgedChildFemaleHumansMaleMiddle AgedNerve FibersPrevalenceRetinal Ganglion CellsRetrospective StudiesHeadacheİdiopathic intracranial hypertensionIIHPapilledemaPseudopapilledemaTransient visual obscurations

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.